muscle-invasive bladder cancer (MIBC), PURE-01 trial, immune checkpoint inhibitor (ICI), BLASST-1 trial, NIAGARA trial, KEYNOTE-866 trial, Pembrolizumab, Distinct Gene Expression Patterns, PD-L1 inhibition, GUSTO trial, KRT20, cT2-4N0M0, H19, CXCL11, CC5.
By Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al., Published on 05/20/20
Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Pashtoon Kasi from City…
This cohort study describes suicide incidence among patients with cancer compared with the general population and by surgical status and cancer treatment.
Meta CEO Mark Zuckerberg said the company plans to up its capital expenditures in 2025 as it aims to keep pace with rivals in the…
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 500+ Peer Reviewed papers,…
Nature Cancer – Shukla and colleagues study the genomic and transcriptomic data of exceptional responders to immunotherapy in renal cell carcinoma and find that such…
Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may…
With algorithms working to trigger reaction, not discern the truth, misinformation – including on climate change – is flourishing and harming democracy, this commentary contends,…
Nature – Analysis of policies for promotion criteria to full professor from academic institutions and government agencies worldwide reveals considerable variation in assessment practices,…
